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The H274Ymutation in the neuraminidase gene of influenza A
(H1N1) has been associated with oseltamivir resistance.1
Initial evaluations of this mutation in animal models sug-
gested that this mutation had reduced fitness and reduced
pathogenicity when compared to corresponding wild-type
viruses.2,3 Earlier reports of clinical infections supported this
view and H274Y was rarely reported.4 However, in the last
year, there have been reports of dramatic increases in the
proportion of H274Y mutations identified in clinical isolates
throughout the world.5 If pathogenicity was indeed compro-
mised in these most recent mutants, then it should be
determined whether patients infected with oseltamivir-
resistant strains are presenting with illness associated with
another co-infecting respiratory viral pathogen. The purpose
of this brief investigation was to determine whether naso-
pharyngeal specimens from patients infected with strains of
influenza A (H1N1) carrying the H274Y mutation were more
likely than not to contain other commonly circulating respira-
tory viral pathogens.
Nasopharyngeal specimens from patients with influenza-
like illness were sent to the Ontario Public Health Labora-
tories. Isolates of influenza A collected from Toronto, Ontario,
Canada (estimated population 2.7 million) during the period
November 14, 2007 to February 14, 2008 were screened by
reverse transcriptase (RT)-PCR for the H1N1 subtype using
primers described previously.6 Strains of isolates were con-
firmed by Sanger sequencing and sequence alignment. Neur-
aminidase gene sequencing was undertaken and sequences
were aligned using CLUSTALX. Isolate sequences were com-
pared to sequenceswith describedH274Ymutations: GenBank
accession No. EU516123 influenza A virus (A/Hawaii/28/
2007(H1N1)); GenBank accession No. CY027037 influenza A
virus (A/Kansas/UR06-0104/2007(H1N1)); GenBank accession
No. EU516027 influenza A virus (A/Texas/31/2007(H1N1)).7
Specimens corresponding toH274Ymutant andH274wild-type
isolateswere blindedand chosen at random for a retrospective
investigation for other respiratory viral pathogens (adeno-
virus, coronavirus 229E/NL63, coronavirus OC43, influenza
A/B, parainfluenza virus 1/2/3, respiratory syncytial virus
A/B, rhinovirus A) using the Seeplex1RVdetectionkit protocol
(Seegene, Inc., Rockville, MD).8 Data analysis was carried out1201-9712/$36.00. CrownCopyright#2008PublishedbyElsevier Ltdonbe
doi:10.1016/j.ijid.2008.07.026usingGraphPad Prism5 (GraphPad Software, Inc., La Jolla, CA,
USA).
All influenza A (H1N1) isolates resembled most closely
influenza A/Solomon Islands/03/06 (H1N1). Of the 19 speci-
mens containing the H274Y mutation, none contained any
other respiratory viral pathogen that could be detected by
the Seeplex RV detection kit protocol. However, two of 40
specimens (5%) containing wild-type H274 influenza A (H1N1)
were also positive for parainfluenza virus 2 and one specimen
(2.5%) was positive for respiratory syncytial virus B. Statis-
tical analysis indicated that there was no difference between
H274Y mutant and H274 wild-type groups in the proportion of
specimens carrying other respiratory viral pathogens (Fish-
er’s exact test, p = 0.5).
Until the pathogenicity of oseltamivir-resistant influenza
A viruses is understood better, infections with these viruses
should be taken seriously by both clinicians and public health
workers.9 The detection of influenza and the lack of other
respiratory viral pathogens detected in the H274Y mutant
group suggest that illness in these patients could only be
associated with influenza and not any other of the more
common respiratory viral pathogens. However, it should be
noted that the interaction of influenza A and bacterial
pathogens could not be determined in these specimens given
issues of specimen collection and data collection. Given the
lack of data supporting a co-infection model, it is considered
that further work must be undertaken to determine the
fitness and virulence of the H274Y mutant influenza A strains
circulating currently.
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